Immunogenicity of Extracellular Vesicles.

Area of Science:

• Biotechnology
• Immunology
• Drug Delivery

Background:

• Extracellular vesicles (EVs) are emerging as potent therapeutic agents and drug delivery systems, demonstrating safety and efficacy in preclinical and early clinical studies.
• Advancing the clinical development of EVs necessitates a thorough understanding of their immunogenicity, moving beyond general immunotoxicity assessments.
• Limited research currently exists on the unintended immunological recognition of EVs, highlighting a critical knowledge gap.

Purpose of the Study:

• To comprehensively review the factors contributing to the immunogenicity of extracellular vesicles (EVs).
• To explore strategies for mitigating unwanted immunological recognition of EVs.
• To enhance the therapeutic benefits of EVs by addressing their immunogenic potential.

Main Methods:

• Literature review of studies investigating EV immunogenicity.
• Analysis of factors influencing EV-immune system interactions.
• Synthesis of current strategies for reducing EV immunogenicity.

Main Results:

• EVs possess inherent properties that can elicit immune responses, impacting their therapeutic application.
• Specific EV components and preparation methods can influence their immunogenic potential.
• Various approaches exist to modulate EV immunogenicity, offering potential for improved therapeutic outcomes.

Conclusions:

• Addressing EV immunogenicity is essential for successful clinical translation of EV-based therapies.
• Developing methods to control immune recognition will broaden the therapeutic utility of EVs.
• Further research into EV immunology is vital for optimizing their design and application as therapeutics.